U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ACHIRAL
Molecular Formula C30H28O8
Molecular Weight 516.5385
Optical Activity NONE
Defined Stereocenters 0 / 0
E/Z Centers 1
Charge 0

SHOW SMILES / InChI
Structure of ROTTLERIN

SMILES

CC(=O)C1=C(O)C(CC2=C(O)C(C(=O)\C=C\C3=CC=CC=C3)=C4OC(C)(C)C=CC4=C2O)=C(O)C(C)=C1O

InChI

InChIKey=DEZFNHCVIZBHBI-ZHACJKMWSA-N
InChI=1S/C30H28O8/c1-15-24(33)19(27(36)22(16(2)31)25(15)34)14-20-26(35)18-12-13-30(3,4)38-29(18)23(28(20)37)21(32)11-10-17-8-6-5-7-9-17/h5-13,33-37H,14H2,1-4H3/b11-10+

HIDE SMILES / InChI

Molecular Formula C30H28O8
Molecular Weight 516.5385
Charge 0
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 1
Optical Activity NONE

Rottlerin is a principal phenolic compound of the Kamala plant Mallotus philippinensis. It was thought to be a selective inhibitor of PKCδ (protein kinase Cδ) (IC50=3-6 uM). It also inhibits PKCα, PKCβ, PKCγ, PKCε, PKCη, PKCζ and eEF2K (CaMK III) (IC50 = 5.3 uM). In HT1080 human fibrosarcoma cells, rottlerin induces apoptosis and autophagy via a PKCδ-independent pathway. When tested on HERG channels, rottlerin increased both step and tail HERG current by leftward shifting the voltage and dependence of HERG activation and slowing channel deactivation. Rottlerin is an inhibitor of Chk2, MAPKAPK-2, Pim-3, PKCλ, PKCθ, Plk, PRAK, SRPK1 and an activator of AMPK and HERG. There have been a number of studies published with evidence against the role of Rotterlin as a specific PKCδ inhibitor.

Approval Year

Targets

Targets

Primary TargetPharmacologyConditionPotency
Target ID: Q12809|||Q9BUT7
Gene ID: 3757.0
Gene Symbol: KCNH2
Target Organism: Homo sapiens (Human)
0.34 µM [EC50]
3.0 µM [IC50]
1.9 µM [IC50]
5.4 µM [IC50]
Conditions

Conditions

ConditionModalityTargetsHighest PhaseProduct
Primary
Unknown

Approved Use

Unknown
Primary
Unknown

Approved Use

Unknown
PubMed

PubMed

TitleDatePubMed
Dieldrin induces apoptosis by promoting caspase-3-dependent proteolytic cleavage of protein kinase Cdelta in dopaminergic cells: relevance to oxidative stress and dopaminergic degeneration.
2003
Induction of cIAP-2 in human colon cancer cells through PKC delta/NF-kappa B.
2003 Dec 19
Ca(2+)-independent protein kinase C activity is required for alpha1-adrenergic-receptor-mediated regulation of ribosomal protein S6 kinases in adult cardiomyocytes.
2003 Jul 15
Allyl alcohol activation of protein kinase C delta leads to cytotoxicity of rat hepatocytes.
2003 May
Involvement of MAP-kinase, PI3-kinase and EGF-receptor in the stimulatory effect of Neurotensin on DNA synthesis in PC3 cells.
2004 Aug 15
Blockade of PKCdelta proteolytic activation by loss of function mutants rescues mesencephalic dopaminergic neurons from methylcyclopentadienyl manganese tricarbonyl (MMT)-induced apoptotic cell death.
2004 Dec
Lipopolysaccharide induces matrix metalloproteinase-9 expression via a mitochondrial reactive oxygen species-p38 kinase-activator protein-1 pathway in Raw 264.7 cells.
2004 Dec 1
PKC-epsilon regulation of extracellular signal-regulated kinase: a potential role in phenylephrine-induced cardiocyte growth.
2004 Jun
Localization of VEGFR-2 and PLD2 in endothelial caveolae is involved in VEGF-induced phosphorylation of MEK and ERK.
2004 May
Gefitinib ("Iressa", ZD1839) inhibits SN38-triggered EGF signals and IL-8 production in gastric cancer cells.
2005 Apr
Doxorubicin requires the sequential activation of caspase-2, protein kinase Cdelta, and c-Jun NH2-terminal kinase to induce apoptosis.
2005 Aug
NGF rapidly increases membrane expression of TRPV1 heat-gated ion channels.
2005 Dec 21
Interferon-alpha-induced expression of phospholipid scramblase 1 through STAT1 requires the sequential activation of protein kinase Cdelta and JNK.
2005 Dec 30
Protein kinase Ctheta activity is involved in the 2,3,7,8-tetrachlorodibenzo-p-dioxin-induced signal transduction pathway leading to apoptosis in L-MAT, a human lymphoblastic T-cell line.
2005 Feb
Phosphorylation-regulated nucleocytoplasmic trafficking of internalized fibroblast growth factor-1.
2005 Feb
PKC delta-induced activation of MAPK pathway is required for bFGF-stimulated proliferation of coronary smooth muscle cells.
2005 Jul 1
Positive and negative transcriptional regulation of aromatase expression in human breast cancer tissue.
2005 May
Cooperation of amphiregulin and insulin-like growth factor-1 inhibits Bax- and Bad-mediated apoptosis via a protein kinase C-dependent pathway in non-small cell lung cancer cells.
2005 May 20
Immunomodulatory drugs (IMiDs) increase the production of IL-2 from stimulated T cells by increasing PKC-theta activation and enhancing the DNA-binding activity of AP-1 but not NF-kappaB, OCT-1, or NF-AT.
2005 Oct
Inhibitory effects of 12-O-tetradecanoylphorbol-13-acetate alone or in combination with all-trans retinoic acid on the growth of cultured human pancreas cancer cells and pancreas tumor xenografts in immunodeficient mice.
2005 Oct
Macrophage migration inhibitory factor: a mediator of matrix metalloproteinase-2 production in rheumatoid arthritis.
2006
Coadministration of sorafenib with rottlerin potently inhibits cell proliferation and migration in human malignant glioma cells.
2006 Dec
Role of PKC isoforms in the Fc(gamma)R-mediated inhibition of LPS-stimulated IL-12 secretion by macrophages.
2006 Feb
Piceatannol upregulates endothelial heme oxygenase-1 expression via novel protein kinase C and tyrosine kinase pathways.
2006 Feb
Retinoid-mediated stimulation of steroid sulfatase activity in myeloid leukemic cell lines requires RARalpha and RXR and involves the phosphoinositide 3-kinase and ERK-MAP kinase pathways.
2006 Feb 1
Increasing ornithine decarboxylase activity is another way of prolactin preventing methotrexate-induced apoptosis: crosstalk between ODC and BCL-2.
2006 Mar
Transcriptional up-regulation of MMP12 and MMP13 by asbestos occurs via a PKCdelta-dependent pathway in murine lung.
2006 May
Mallotoxin is a novel human ether-a-go-go-related gene (hERG) potassium channel activator.
2006 Nov
Acetaldehyde inhibits PPARgamma via H2O2-mediated c-Abl activation in human hepatic stellate cells.
2006 Oct
Microarray-based kinase inhibition assay by gold nanoparticle probes.
2007 Jan 15
Involvement of protein kinase Cdelta in iron chelator-induced IL-8 production in human intestinal epithelial cells.
2007 Jan 9
Acrolein induces cyclooxygenase-2 and prostaglandin production in human umbilical vein endothelial cells: roles of p38 MAP kinase.
2007 Jun
Curcumin-induced GADD153 upregulation: modulation by glutathione.
2007 May 15
Cytotoxicity of paraquat in microglial cells: Involvement of PKCdelta- and ERK1/2-dependent NADPH oxidase.
2007 Sep 5
Heme oxygenase-1 mediates the anti-inflammatory effect of Curcumin within LPS-stimulated human monocytes.
2008 Jun
Protein kinase Cdelta stimulates proteasome-dependent degradation of C/EBPalpha during apoptosis induction of leukemic cells.
2009 Aug 7
Induction of COX-2 in human airway cells by manganese: role of PI3K/PKB, p38 MAPK, PKCs, Src, and glutathione depletion.
2009 Feb
Screen for chemical modulators of autophagy reveals novel therapeutic inhibitors of mTORC1 signaling.
2009 Sep 22
Puerarin suppresses AGEs-induced inflammation in mouse mesangial cells: a possible pathway through the induction of heme oxygenase-1 expression.
2010 Apr 15
3-Caffeoyl, 4-dihydrocaffeoylquinic acid from Salicornia herbacea inhibits tumor cell invasion by regulating protein kinase C-delta-dependent matrix metalloproteinase-9 expression.
2010 Oct 5
Lead-induced accumulation of beta-amyloid in the choroid plexus: role of low density lipoprotein receptor protein-1 and protein kinase C.
2010 Sep
Protective role of taurine against arsenic-induced mitochondria-dependent hepatic apoptosis via the inhibition of PKCdelta-JNK pathway.
2010 Sep 7
Dual function of protein kinase C (PKC) in 12-O-tetradecanoylphorbol-13-acetate (TPA)-induced manganese superoxide dismutase (MnSOD) expression: activation of CREB and FOXO3a by PKC-alpha phosphorylation and by PKC-mediated inactivation of Akt, respectively.
2011 Aug 26
Inhibition of PKCδ reduces cisplatin-induced nephrotoxicity without blocking chemotherapeutic efficacy in mouse models of cancer.
2011 Jul
Lipid raft-dependent death receptor 5 (DR5) expression and activation are critical for ursodeoxycholic acid-induced apoptosis in gastric cancer cells.
2011 May
Rottlerin induces apoptosis of HT29 colon carcinoma cells through NAG-1 upregulation via an ERK and p38 MAPK-dependent and PKC δ-independent mechanism.
2012 Apr 15
Isorhamnetin protects against oxidative stress by activating Nrf2 and inducing the expression of its target genes.
2014 Jan 15
Naringin protects against anoxia/reoxygenation-induced apoptosis in H9c2 cells via the Nrf2 signaling pathway.
2015 Apr
A HAMP promoter bioassay system for identifying chemical compounds that modulate hepcidin expression.
2015 May
Protein kinase Cδ mediates trimethyltin-induced neurotoxicity in mice in vivo via inhibition of glutathione defense mechanism.
2016 Apr
Patents

Sample Use Guides

Xenograft tumor model in nude mice: mice were randomized into 4 treatment groups (control, DMSO, rottlerin 4 mg/kg, and rottlerin 2 mg/kg) with 5 mice per group. All the mice were injected intraperitoneally daily for 4 weeks. Tumors were smaller in the experimental groups than the control and DSMO groups, and tumors were smaller in the rottlerin 4 mg/kg group than the rottlerin 2 mg/kg group.
Route of Administration: Intraperitoneal
To inhibit the activity of PKCdelta, either the natural compound rottlerin was transiently applied to the culture medium of high density cell cultures (HDC) in 2.5, 5 or 10 uM concentrations.
Substance Class Chemical
Created
by admin
on Fri Dec 15 19:00:15 GMT 2023
Edited
by admin
on Fri Dec 15 19:00:15 GMT 2023
Record UNII
E29LP3ZMUH
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
ROTTLERIN
MI  
Common Name English
NSC-94525
Code English
KAMALIN
Common Name English
(2E)-1-(6-(3-ACETYL-2,4,6-TRIHYDROXY-5-METHYLBENZYL)-5,7-DIHYDROXY-2,2-DIMETHYL-2H-CHROMEN-8-YL)-3-PHENYLPROP-2-EN-1-ONE
Systematic Name English
ROTTLERIN [MI]
Common Name English
5,7-DIHYDROXY-2,2-DIMETHYL-6-(2,4,6-TRIHYDROXY-3-METHYL-5-ACETYLBENZYL)-8-CINNAMOYL-1,2-CHROMENE
Common Name English
MALLOTOXIN
Common Name English
NSC-56346
Code English
Code System Code Type Description
EPA CompTox
DTXSID30231502
Created by admin on Fri Dec 15 19:00:15 GMT 2023 , Edited by admin on Fri Dec 15 19:00:15 GMT 2023
PRIMARY
WIKIPEDIA
Rottlerin
Created by admin on Fri Dec 15 19:00:15 GMT 2023 , Edited by admin on Fri Dec 15 19:00:15 GMT 2023
PRIMARY
CAS
82-08-6
Created by admin on Fri Dec 15 19:00:15 GMT 2023 , Edited by admin on Fri Dec 15 19:00:15 GMT 2023
PRIMARY
FDA UNII
E29LP3ZMUH
Created by admin on Fri Dec 15 19:00:15 GMT 2023 , Edited by admin on Fri Dec 15 19:00:15 GMT 2023
PRIMARY
CHEBI
8899
Created by admin on Fri Dec 15 19:00:15 GMT 2023 , Edited by admin on Fri Dec 15 19:00:15 GMT 2023
PRIMARY
PUBCHEM
5281847
Created by admin on Fri Dec 15 19:00:15 GMT 2023 , Edited by admin on Fri Dec 15 19:00:15 GMT 2023
PRIMARY
MESH
C085746
Created by admin on Fri Dec 15 19:00:15 GMT 2023 , Edited by admin on Fri Dec 15 19:00:15 GMT 2023
PRIMARY
NSC
94525
Created by admin on Fri Dec 15 19:00:15 GMT 2023 , Edited by admin on Fri Dec 15 19:00:15 GMT 2023
PRIMARY
MERCK INDEX
m9675
Created by admin on Fri Dec 15 19:00:15 GMT 2023 , Edited by admin on Fri Dec 15 19:00:15 GMT 2023
PRIMARY Merck Index
NSC
56346
Created by admin on Fri Dec 15 19:00:15 GMT 2023 , Edited by admin on Fri Dec 15 19:00:15 GMT 2023
PRIMARY
ECHA (EC/EINECS)
201-395-4
Created by admin on Fri Dec 15 19:00:15 GMT 2023 , Edited by admin on Fri Dec 15 19:00:15 GMT 2023
PRIMARY